Mimedx (MDXG) Assets Average (2011 - 2026)
Mimedx (MDXG) reported Assets Average of $325.7 million for Q1 2026, up 21.9% on a YoY basis from $267.2 million in Q1 2025, and down 1.56% sequentially from $330.8 million in Q4 2025.
Mimedx (MDXG) Assets Average (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 15 years of Assets Average data on file, last reported at $325.7 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 21.9% year-over-year to $325.7 million; the trailing twelve-month figure through Mar 2026 stood at $325.7 million (up 21.9% YoY), and the FY2025 full-year result was $303.3 million, up 20.6% from the prior year.
- Assets Average eased to $325.7 million in Q1 2026, from $330.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $330.8 million in Q4 2025 to a low of $169.8 million in Q1 2023.
- A 5-year average of $228.9 million and a median of $225.9 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average declined 9.22% in 2022 and soared 35.67% in 2024, its largest moves.
- Tracing MDXG's Assets Average over 5 years: stood at $172.1 million in 2022, then grew by 24.36% to $214.0 million in 2023, then climbed by 18.63% to $253.9 million in 2024, then soared by 30.29% to $330.8 million in 2025, then decreased by 1.56% to $325.7 million in 2026.
- Business Quant data shows MDXG's Assets Average at $325.7 million in Q1 2026, $330.8 million in Q4 2025, and $305.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 325.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.66 Mn |
| Dec 31, 2025 | 330.82 Mn |
| Sep 30, 2025 | 305.05 Mn |
| Jun 30, 2025 | 280.76 Mn |
| Mar 31, 2025 | 267.17 Mn |
| Dec 31, 2024 | 253.90 Mn |
| Sep 30, 2024 | 237.04 Mn |
| Jun 30, 2024 | 225.93 Mn |
| Mar 31, 2024 | 230.36 Mn |
| Dec 31, 2023 | 214.03 Mn |
| Sep 30, 2023 | 182.70 Mn |
| Jun 30, 2023 | 172.27 Mn |
| Mar 31, 2023 | 169.79 Mn |
| Dec 31, 2022 | 172.11 Mn |
| Sep 30, 2022 | 170.73 Mn |
| Jun 30, 2022 | 171.56 Mn |
| Mar 31, 2022 | 181.19 Mn |
| Dec 31, 2021 | 184.23 Mn |
| Sep 30, 2021 | 183.84 Mn |
| Jun 30, 2021 | 188.98 Mn |